FDA Investigator James P Finn

James P Finn has conducted inspections on 118 sites in 4 countries as of 17 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
118
Last Inspection Date:
17 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100003493
Countries of Inspections:
United States of America, Spain, Ireland, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with James P Finn:
Abby E Pelletier, Alan R Condon, Allison A Rodriguez, Althea A Williams, Amber G Wardwell, Amy M Cramer, Andrew J Garufi, Anthony W Thomas, Brandi L Garbutt, Brenda P King, Carla C Cummins, Carla C Tuite, Christopher K Vantwuyver, Crystal Nevins, Darin S Wiegers, David C Sullivan, David J Feria, David P Vanhouten, Dawn M Braswell, Diane M Biron, Dolores Harper, Dorothy W Lee, Elizabeth B Griffin, Elmiloudi M Sarhrani, Eric C Schmitt, Evelyn Taha, Fouad Attioui, George T Allen, Jr, Gerard D Difiore, Goushi Kubota, Holly S Simms, Hugh M Mcclure, II, Iris C Macinnes, James D Planchon, James H Tanner, James W Whitney, Jason A Rossi, Jeffrey J Thibodeau, Joey C West, John A Sciacchitano, Jonathan B Lewis, Jonathan G Matrisciano, Joseph C Teixeira, Justine M Corson, Kalkidan A Molla, Karen Mcnabb Noon, Kayla R Huffman, Kent A Conforti, Kwong P Lee, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Marcia M Laughrey, Margaret E Walsh, Mark E Farrell, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Megan A Haggerty, Meredith L Miller, Michael J Nerz, Michael P Sweeney, Michelle M Noe Varga, Mutahar S Shamsi, Nabil Nakhoul, Nassim Ben Makhlouf, Norman Wong, Osama A Khatib, Pamela L Ogonowski, Patrick M Regan, Paul A Bonneau, Paul M Gelfand, Paul P Geraci, Pauline N Logan, Philip H Lafleur, Preston M Lee, Richard K Vogel, Sandra P White, Sara M Onyango, Sara M Richardson, Seth A Mailhot, Shawn M Bogdan, Sherry M Nisson, Stephen C Smith, Sunita Pandey, Suzanne M Healy, Tamara S Rosbury, Teddy Tom, Terry C Kimball, Theresa M To, Thomas Cote, Thomas Siebertz, William K Dagley, Yehualashet A Gessesse

James P Finn's Documents

Publish Date Document Type Title
March, 2020 FDA 483 Q Urological - Form 483, 2020-03-16
October, 2023 FDA 483 Cirtronics Corporation - Form 483, 2023-10-12
September, 2023 FDA 483 Agile Devices, Inc. - Form 483, 2023-09-15
June, 2016 FDA 483 Respiratory Delivery Systems - Form 483, 2016-06-16
February, 2016 FDA 483 Cellay, Inc - Form 483, 2016-02-10
November, 2021 FDA 483 Bose Corporation - Form 483, 2021-11-12
March, 2017 EIR Spectra Medical Devices, LLC - EIR, 2017-03-30
January, 2022 FDA 483 Breas Medical, Inc. - Form 483, 2022-01-18
August, 2022 FDA 483 Bio-Signal Group Corp. - Form 483, 2022-08-30
February, 2017 FDA 483 Candela Corporation - Form 483, 2017-03-08
February, 2023 FDA 483 PHASE-N Corporation - Form 483, 2023-02-09
December, 2023 FDA 483 Philips North America - Form 483, 2023-12-13
March, 2016 FDA 483 Pavo, Inc. - Form 483, 2016-03-28
September, 2016 FDA 483 Concert Medical, LLC - Form 483, 2016-09-20
November, 2022 FDA 483 Paragonix Technologies Inc. - Form 483, 2022-11-03
October, 2019 FDA 483 Flowonix Medical Inc - Form 483, 2019-10-11
November, 2022 FDA 483 Spirus Medical, LLC - Form 483, 2022-11-18
October, 2020 EIR Abiomed, Inc. - EIR, 2020-10-06
November, 2023 FDA 483 Hamilton Thorne, Inc - Form 483, 2023-11-09
March, 2017 FDA 483 Lilypad Scales, Inc. - Form 483, 2017-03-17
March, 2022 FDA 483 Phoenix Diagnostics, Inc. - Form 483, 2022-03-17
March, 2017 FDA 483 Response Spectra Medical Devices, LLC - Form 483R, 2017-04-14
January, 2016 FDA 483 Rhode Island Novelty Inc. - Form 483, 2016-01-25
February, 2022 FDA 483 Aurora Healthcare US Corp - Form 483, 2022-02-17
January, 2024 FDA 483 Corindus, Inc. - Form 483, 2024-01-25
February, 2017 FDA 483 Symmetry Medical Manufacturing, Inc. - Form 483, 2017-02-16
October, 2022 FDA 483 Fresh Pond Ventures, LLC dba Firefly Global - Form 483, 2022-10-11
January, 2017 FDA 483 UFP Technologies, Inc. - Form 483, 2017-01-17
May, 2017 FDA 483 Morgan Scientific, Inc. - Form 483, 2017-05-15
October, 2017 FDA 483 Hemedex, Inc. - Form 483, 2017-10-05
July, 2019 FDA 483 Cogstate Inc. - Form 483, 2019-07-24
February, 2016 FDA 483 Schuerch Corporation - Form 483, 2016-02-12
January, 2023 FDA 483 Gelesis, Inc. - Form 483, 2023-01-25
August, 2021 FDA 483 SafePath Medical, Inc. - Form 483, 2021-08-25
February, 2020 FDA 483 Bionik, Inc. - Form 483, 2020-02-10
October, 2021 FDA 483 Little Sparrows Technologies, Inc. - Form 483, 2021-10-20
August, 2019 FDA 483 Holistic Technologies, LLC - Form 483, 2019-08-23
January, 2020 FDA 483 Tomy International Inc. - Form 483, 2020-01-13
July, 2015 FDA 483 Ace Surgical Supply Co., Inc. - Form 483, 2015-07-23
April, 2022 FDA 483 Health Care Technology - Form 483, 2022-04-25
March, 2023 FDA 483 Barrett Technology, LLC - Form 483, 2023-03-07
January, 2018 FDA 483 Boston Eye Design, LLC - Form 483, 2018-01-29
July, 2016 FDA 483 AliMed Corporation - Form 483, 2016-07-07
February, 2018 FDA 483 Fresh Pond Ventures, LLC dba Firefly Global - Form 483, 2018-02-21
July, 2017 FDA 483 Denali R & D Corporation - Form 483, 2017-07-12
November, 2019 FDA 483 Consolidated Machine Corp. - Form 483, 2019-11-27
December, 2019 FDA 483 Applied Tissue Technologies LLC - Form 483, 2019-12-11
April, 2018 EIR InfuTronix LLC - EIR, 2018-04-05
July, 2021 FDA 483 Marine Polymer Technologies - Form 483, 2021-07-19
August, 2022 FDA 483 Health Beacons, Inc. - Form 483, 2022-08-03
July, 2022 FDA 483 Signifier Medical Technologies, Llc - Form 483, 2022-07-15
May, 2022 FDA 483 BK Medical Holding Company - Form 483, 2022-05-27
October, 2019 EIR Flowonix Medical Inc - EIR, 2019-10-29
April, 2024 FDA 483 Polygon Medical, Inc. - Form 483, 2024-04-25
May, 2024 FDA 483 Akili Interactive Labs, Inc. - Form 483, 2024-05-23
February, 2024 FDA 483 Novocure, Inc - Form 483, 2024-02-09
April, 2024 FDA 483 Ophthalmic Labs, Inc. - Form 483, 2024-04-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more